New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2014
09:35 EDTFDX, GILD, TWTR, GOOG, BIDU, MSFT, AAPLActive equity options trading on open
Active equity options trading on open according to Track Data: TWTR NFLX BIDU GILD MSFT GOOG FDX AAPL
News For TWTR;AAPL;BIDU;GILD;MSFT;GOOG;FDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | all recent news | >>
April 6, 2015
11:30 EDTTWTROptions with increasing implied volatility
Subscribe for More Information
10:23 EDTAAPLApple Maps searches no longer showing just Yelp, AppleInsider reports
Searches on Apple (AAPL) Maps, which previously relied solely on Yelp (YELP) to provide reviews for local search, are now pulling results from TripAdvisor (TRIP) and Priceline's (PCLN) Booking.com, AppleInsider reported yesterday. Neither TripAdvisor or Booking.com are listed as sources on Apple's official Maps attribution webpage, but reviews with links to their respective webpages and apps are now appearing in Maps queries, the blog added. Shares of Yelp are down 1% to $46.67 in early trading. Reference Link
10:02 EDTMSFTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:56 EDTGOOGGoogle in talks with Hutchison for cheaper overseas calls, Telegraph reports
Subscribe for More Information
09:36 EDTAAPL, GOOGActive equity options trading on open
Subscribe for More Information
09:04 EDTTWTRTwitter says 'aware of reports of interruption of service in Turkey'
Subscribe for More Information
07:45 EDTMSFTMicrosoft upgraded at Wells Fargo
Subscribe for More Information
07:36 EDTGILDGilead Q1 HCV revenue poised to beat expectations, says RBC Capital
After analyzing weekly prescription data, RBC Capital believes that Gilead's weekly hepatitis C prescriptions are tracking towards $3.5B-$3.6B of revenue from hepatitis C drugs for Q1, versus the consensus outlook of about $2.6B. The firm keeps an Outperform rating on Gilead.
07:34 EDTMSFTWells Fargo upgrades Microsoft on improved strategic position
Subscribe for More Information
07:29 EDTAAPLApple Watch cannot launch in Switzerland due to patent issue, Reuters says
Subscribe for More Information
06:32 EDTGOOGGoogle Ventures-backed Buttercoin to shut down
Subscribe for More Information
06:31 EDTMSFTMicrosoft upgraded to Outperform from Market Perform at Wells Fargo
Subscribe for More Information
06:28 EDTMSFTMicrosoft completes latest round of layoffs, Business Insider reports
Microsoft has completed its latest round of layoffs in a move to "remove role overlap, optimize activities and functions, align disciplines with the rest of Microsoft, and, perhaps most importantly, reshape IT for the skills we need to transform," Business Insider reports, citing an email from Chief Information Officer Jim DuBois. A company spokesperson commented that the company believes this will be the "last of the anticipated broad cuts as part of the restructuring plan announced last July." Though it is unclear how many employees were laid off in this round, affected workers are coming from Microsoft's divisions and not focused on former Nokia employees. Reference Link
06:20 EDTAAPLGarmin downgraded to Sell from Buy at Citigroup
Citigroup analyst Jeremy David downgraded Garmin two notches to Sell from Buy saying competitive pressures are likely to stall the growth of the company's GPS fitness watch business. He also thinks revenue trends in Garmin's Outdoor segment could disappoint as the year progresses. David expects Garmin to miss consensus earnings and revenue expectations in Q1 and views the Apple (AAPL) Watch launch as another potential negative catalyst for shares. He cut his price target for the stock to $42 from $68. Shares of the navigation and information device maker closed Thursday down 58c to $46.49 after Goldman Sachs downgraded the stock Neutral from Buy.
06:11 EDTAAPLSamsung expected to win A9 chip orders for next iPhone, Bloomberg reports
Subscribe for More Information
05:54 EDTGOOGYouTube planning advertising campaign aimed at Canada, Globe and Mail says
Subscribe for More Information
April 5, 2015
16:56 EDTGOOG, AAPLEU considers major probe into Internet platforms, WSJ says
Subscribe for More Information
14:43 EDTGILDActavis seeks FDA approval to market generic version of Gilead's Letairis
Actavis (ACT) on Friday, confirmed that it has filed an Abbreviated New Drug Application with the FDA seeking approval to market Ambrisentan Tablets, 5 mg and 10 mg. Actavis' ANDA product is a generic version of Gilead Science's (GILD) Letairis, which is a treatment for pulmonary arterial hypertension. Gilead Sciences and Royalty Pharma Collection Trust filed suit against Actavis on April 1, in the U.S. District Court for the District of Delaware seeking to prevent Actavis from commercializing its ANDA product prior to the expiration of U.S. Patent number RE42,462. The lawsuit was filed under the provisions of the Hatch-Waxman Act, resulting in a stay of final FDA approval of Actavis' ANDA for up to 30 months from the date the plaintiffs received notice of Actavis' ANDA filing or until final resolution of the matter before the court, whichever occurs sooner, subject to any other exclusivities. Based on available information, Actavis believes it may be a "first applicant" to file an ANDA for the generic version of Letairis and, should its ANDA be approved, may be entitled to 180 days of generic market exclusivity. For the 12 months ending December 31, Letairis had global sales of approximately $595M, according to Gilead.
14:32 EDTGOOGAntitrust suit against Google over Android app limits dropped, Reuters says
Subscribe for More Information
09:10 EDTAAPLApple Watch to be sold by appointment only, Barron's says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use